Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06551857
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-03
Brief Title:
The Effect of Cancer Treatments on Speech Perception in Noise Cognition and Hearing-Related Quality of Life
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Effect of Cancer Treatments on Speech Perception in Noise Cognition and Hearing-Related Quality of Life
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CaSPiN
Brief Summary:
The study will assess the effect of cancer treatments on speech perception in noise cognition and hearing-related quality of life by monitoring 200 cancer patients receiving standard care for their underlying malignancy
Detailed Description:
The study will assess the effects of four different types of cancer treatments on speech perception in noise hearing thresholds cognition and hearing-related quality of life over a follow-up period of 3 years
The speech perception in noise will be assessed using the Finnish matrix sentence test Other hearing measures include transient and distortion product otoacoustic emissions impedance audiometry and pure-tone audiometry extending to high frequencies 0125kHz - 16kHz
Hearing-related quality of life will be assessed using Speech Spatial and Qualities 12 -questionnaire Vanderbilt Fatigue Scale 10 -questionnaire and Tinnitus Handicap Index Cognitive functions will be assed using Functional Assessment of Cancer Therapy - Cognitive Function FACT-Cog questionnaire and neuropsychological tests The neuropsychological tests included in the study are Continuous Performance Test Continuous Auditory Test of Attention Trail Making Test A B Stroop Test Coding and Digit span tasks from the Wechsler Adult Intelligence Scale - Fourth Edition Word List task from Wechsler Memory Scale III and Controlled Oral Word Association Test
Neuropsychological assessments will be conducted at baseline and 1 year and 3 years after the end of the treatments All other assessments will be conducted at baseline and at 3-4 months 1 year and 3 years after the end of the initial treatments
The speech perception in noise will be assessed using the Finnish matrix sentence test Other hearing measures include transient and distortion product otoacoustic emissions impedance audiometry and pure-tone audiometry extending to high frequencies 0125kHz - 16kHz
Hearing-related quality of life will be assessed using Speech Spatial and Qualities 12 -questionnaire Vanderbilt Fatigue Scale 10 -questionnaire and Tinnitus Handicap Index Cognitive functions will be assed using Functional Assessment of Cancer Therapy - Cognitive Function FACT-Cog questionnaire and neuropsychological tests The neuropsychological tests included in the study are Continuous Performance Test Continuous Auditory Test of Attention Trail Making Test A B Stroop Test Coding and Digit span tasks from the Wechsler Adult Intelligence Scale - Fourth Edition Word List task from Wechsler Memory Scale III and Controlled Oral Word Association Test
Neuropsychological assessments will be conducted at baseline and 1 year and 3 years after the end of the treatments All other assessments will be conducted at baseline and at 3-4 months 1 year and 3 years after the end of the initial treatments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None